More than eight months after a panel of physicians recommended that two pain-related ailments be included in the state’s medical cannabis program, the General Assembly’s only bipartisan committee on Tuesday approved them. It’s an example of a not-so nimble process that resulted from months of review and rewriting by the state attorney general and the
More than eight months after a panel of physicians recommended that two pain-related ailments be included in the state’s medical cannabis program, the General Assembly’s only bipartisan committee on Tuesday approved them.
It’s an example of a not-so nimble process that resulted from months of review and rewriting by the state attorney general and the nonpartisan Legislative Commissioner’s Office. The vote brings the total number of afflications for adults to 38, while there are 10 for those under the age of 18.
During a quick, three-minute discussion and vote – hindered only slightly by the video conference for committee members and staff – the legislative Regulation Review Committee approved the regulations, which will now allow patients suffering chronic pain of at least six months duration and those with Ehlers-Danlos Syndrome to join the eight-year-old medical marijuana program, which currently has 41,292 patients and 1,270 enrolled physicians.
